RecallRadar
FDA · DrugsClass I

Green Lumber Holdings, LLC drug recall: Green Lumber Natural Fuel For Men capsule

Key facts

Agency
U.S. Food and Drug Administration (FDA)
Program
Drugs
Classification
Class I
Status
Ongoing
Event ID
97526
Recall initiated
Aug 28, 2025
Classified by FDA
Feb 10, 2026
Posted in Enforcement Report
Feb 11, 2026
Recalling firm
Green Lumber Holdings, LLC
Firm location
Corona Del Mar, CA, United States
Initiated by
Voluntary: Firm initiated
Firm notified customers by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Products in this event
1

What to do

Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.

View the official FDA record ↗

Reason for recall

Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil

What the classification means

  • Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.

About this recall

The firm started this recall on Aug 28, 2025. FDA classified it 166 days later, on Feb 10, 2026. Distribution reported by FDA: Nationwide Green Lumber Holdings, LLC has 2 recalls in our records.

Recalled products (1)

  • D-0304-2026 Class I Ongoing

    Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660

    Codes / lots: LOT308EXP03/28

Source and freshness

Source
U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
Official notice
FDA Enforcement Report, event 97526
Raw record
openFDA API (JSON)
Dataset last updated by FDA
Nov 3, 2026
Imported by RecallRadar
Nov 4, 2026

Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.